LG Household & Healthcare (051900) fair value: what the stock is really worth
As of Sep 23, 2026: fair value of LG Household & Healthcare KRW 197,812, price KRW 292,500, upside -32.4%, quality 57 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch LG Household & Healthcare for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range 215,000 KRW – 1,693,144 KRW · fair‑value band 148,303 KRW – 247,322 KRW · the 292,500 KRW price screens above the 197,812 KRW fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow LG Household & Healthcare in your weekly email
Every Wednesday you see whether LG Household & Healthcare is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
LG H&H Co., Ltd. operates as cosmetics, household goods, and beverage company in South Korea and internationally.
Show more
LG H&H Co., Ltd. operates as cosmetics, household goods, and beverage company in South Korea and internationally. The company offers cosmetics under The History of Whoo, O HUI, SU:M37, belif, ISA KNOX, Sooryehan, CODE GLOKOLOR, VONIN, CAREZONE, The Saga of Xiu, BEYOND, CNP, CNP Rx, VDL, VDIVOV, Nature Collection, THEFACESHOP, fmgt, DR.Belmeur, Yehwadam, and BEAUTE brands; toothpaste, toothbrush, mouthwash, and whitening products under the Perioe, Bamboosalt, and REACH brands; hair care products, including shampoo, conditioner, and hair treatment products under the Elastine, Organist, ReEn, Dr. Groot, and Silk Therapy brands; and skin and body care products under the Veilment and Physiogel Hypoallergenic brands. It also provides fabric softeners under the Saffron, Saffron AURA, and Saffron Care brands; housekeeping solutions, such as baking soda, sodium percarbonate, and citric acid under the Han.Ip; detergent under the Pongpong, SAFE, TECH, SuperTie, and FiJi brands; bleach under the Oxygen Clean brand; home cleaning products under the Homestar brand; dishwashing under the Jayeonpong brand; fragrance under the Aura brand; baby care products under the Babience and method brands; pet care products under the Sirius brand; gift sets; and mini travel kits under the MINIS brand. In addition, the company offers sparking and bottled water, juices, tea and coffee, sports and energy drinks, and lifestyle beverages under the Coca-Cola, Coke Zero, Coca-Cola light, Fanta, SPRITE, SPRITE KINCIDER, SCHWEPPES, Dr.Pepper, CANADA DRY, Seagram's, Crushed pear cider, Minute Maid, Minute Maid Qoo, Minute Maid Joy, Sunkist, Gwailchon, Cocoplam, Crushed Pear, Bong Bong, GEORGIA, Mate Tea of the Sun, Secret W, Real Leaf, POWERADE, TORETA, Monster Energy, Guronsan, ViO DIAMOND, ViO DIAMOND EC, ViO Soonsoo, Pyeongchang Water, GLACEAU vitamin water, and GO:GOOD brands. It operates through stores. LG H&H Co., Ltd. was founded in 1947 and is headquartered in Seoul, South Korea.
Stock analysis
LG Household & Healthcare (051900) currently trades at 292,500 KRW, while our model-based Fair Value estimate is 197,812 KRW, implying the stock looks roughly 47.9% overvalued today.
Show more
Valuation
Bull case: the DCF Models group reads highest at a median of 361,201 KRW per share, and 8 of the 14 models we run sit above the 292,500 KRW price.
Bear case: the Earnings-Based group reads lowest at 142,492 KRW, and 6 of the 14 models stay below the price. Evidence for this calculation is medium.
Scenario range: 148,303 KRW (bear) to 247,322 KRW (bull), the price of 292,500 KRW sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 57/100 (solid quality), in the Consumer Defensive sector.
Weak Growth: Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
LG Household & Healthcare reported revenue of 6.4T KRW in FY2025 versus 8.1T KRW in FY2021, a compound −5.9%/yr. Reported net income was −100B KRW in FY2025.
Key figures
Market cap 4.3T KRW (≈ $3.0B) · P/S ratio 0.65 · Dividend yield 0.7% · Net margin −1.6% · Return on equity −1.8% · Return on assets (EBIT) 8.5% · Operating margin 6.8% · Revenue (TTM) 6.2T KRW.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 47 out of 100 (low confidence).
What moves the price
The share trades about 12% below its 52-week high and 36% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Consumer Defensive peers we cover trades at −25% fair-value upside, at −32%, 051900 screens richer than that median.
Fair Value models
Bear 148,303 KRWFair Value 197,812 KRWBull 247,322 KRW
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.40/100
Revenue growth is inconsistent: the periods point in different directions, so there is no trend to rely on.
Revenue growth 1 year
−6.7%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−4.0%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.5%
Start year 2020 (pandemic). Over 10 years: +1.8% a year
Revenue growth 23 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+7.7%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
’25
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
17.8% (2020) → 2.7% (2025)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2025 is a loss year, no rate is defined from a loss
not computed
Growth Forecast
Little optimism in the price
The price assumes less growth than the company has delivered so far and less than analysts expect.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
−6.8%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect ⓘAnalysts publish sales forecasts for the next two fiscal years. For the years after that, growth slows evenly to 2 % a year by year ten (2 % is the long-run rate our models use). Projected years are marked as such.
+2.4%
Yearly sales growth analysts expect, extended to five years.
After inflation (South Korea: IMF forecast 2.1% a year to 2030, 2.1% from 2016 to 2025) that is about −8.7% a year for the price and +0.3% for the forecasts.
Compare LG Household & Healthcare with another stock
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Household & Personal Products · 246 stocks
Beats the industry median on 1/9 measures
Overall it trails its industry peers.
Valuation
Quality Score57 · Below median
Fair Value upside−32% · Below median
Profitability
Return on assets1% · Below median
Net margin (TTM)−2% · Bottom 25%
Operating margin (TTM)7% · Below median
Growth and dividend
Revenue growth−7% · Bottom 25%
Dividend yield (TTM)0.7% · Bottom 25%
Valuation Multiplesvs Household & Personal Products median · lower = cheaper
P/FCF0.0× · Cheapest 25%
PEG4.44× · Priciest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)0· sector 33
FUTURE (revenue growth)0· sector 9
PAST (return on equity)0· sector 27
HEALTH (low debt)100· sector 98
DIVIDEND (yield)14· sector 55
VALUE 0: the price sits above our fair-value range.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is LG Household & Healthcare (051900) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 197,812 KRW versus a price of 292,500 KRW, about −32% upside (overvalued).
What is the fair value of 051900?
Our model-based fair value for LG Household & Healthcare is 197,812 KRW (as of Sep 24, 2026), built from audited fundamentals. The current price: 292,500 KRW.
What is the quality score of 051900?
LG Household & Healthcare has a Quality Score of 57/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for LG Household & Healthcare (051900)?
Our model-based price target is the fair value of 197,812 KRW (as of Sep 24, 2026) from 14 valuation models. Cautious scenario 148,303 KRW, optimistic scenario 247,322 KRW. It is a calculation from audited fundamentals, not an analyst target.
What is the LG Household & Healthcare stock forecast for 2026?
Our models put fair value at 197,812 KRW, about −32% upside versus a price of 292,500 KRW (overvalued). Cautious scenario 148,303 KRW, optimistic scenario 247,322 KRW. The calculation is refreshed regularly with new filings.
What is the revenue of LG Household & Healthcare (051900)?
LG Household & Healthcare reported trailing-twelve-month revenue of about 6.2T KRW (latest available figure, as of Sep 24, 2026).
Does LG Household & Healthcare pay a dividend?
LG Household & Healthcare currently shows a dividend yield of about 0.68% relative to its recent price (as of Sep 24, 2026).
What growth is priced into LG Household & Healthcare (051900)?
For today's price to be fair in a discounted-cash-flow model, LG Household & Healthcare would have to grow free cash flow by -6.8 % per year for five years (discount rate 8.7 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +7.5 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 051900 use?
Our models discount LG Household & Healthcare at 8.7 %: a base by market capitalisation (mega), damped by beta 0.79, country premium for South Korea. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For LG Household & Healthcare that is -6.8 % per year a year over ten years, using the same discount rate (8.7 %) and the same formula as our fair value.
How much growth has LG Household & Healthcare (051900) delivered so far?
Over the past 5 years revenue at LG Household & Healthcare grew +7.5 % a year. The price currently implies -6.8 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of LG Household & Healthcare (051900) growing?
The median revenue growth in the sector is +2.7 % a year. That is the yardstick for the growth priced into LG Household & Healthcare (-6.8 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of LG Household & Healthcare (051900)?
The free-cash-flow yield on the price is 8.20 %: that much free cash flow LG Household & Healthcare produces per unit of market value. When it exceeds the discount rate of our models (8.7 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of LG Household & Healthcare (051900)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For LG Household & Healthcare it is 197,812 KRW per share (as of Sep 24, 2026), against a price of 292,500 KRW. It is the blended result of 14 valuation models (cash flow, earnings, asset, dividend).
Is LG Household & Healthcare stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 051900 trades above its calculated fair value: price 292,500 KRW, fair value 197,812 KRW, a gap of about −32% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 051900?
No. The price is what the market pays today (292,500 KRW); the fair value is what the company's own numbers justify (197,812 KRW). For LG Household & Healthcare the two are 94,688 KRW per share apart. That gap is exactly why we show both numbers side by side.
How much is LG Household & Healthcare worth?
The market values LG Household & Healthcare at about 4.3T KRW (market capitalisation, as of Sep 24, 2026). Per share that is 292,500 KRW; our models calculate a fair value of 197,812 KRW per share.
What do the bullish and bearish scenarios say about 051900?
Our models span a range for LG Household & Healthcare: cautious scenario 148,303 KRW, base 197,812 KRW, optimistic 247,322 KRW per share (as of Sep 24, 2026, price 292,500 KRW). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the PEG ratio of 051900?
The PEG ratio of LG Household & Healthcare is 4.44 (P/E divided by earnings growth, as of Sep 24, 2026). That is above 1, so the growth is already paid for in the price.
How solid is the balance sheet of LG Household & Healthcare (051900)?
Balance-sheet figures for LG Household & Healthcare (as of Sep 24, 2026): return on equity −1.8%. They feed the Quality Score of 57/100, which measures business quality independently of the share price.
How far is 051900 from its 52-week high?
LG Household & Healthcare trades at 292,500 KRW, about 12% below its 52-week high of 333,500 KRW and 36% above the low of 215,000 KRW (as of Sep 23, 2026). Distance from the high says nothing about value: that is what the fair value of 197,812 KRW is for.
Which stocks are comparable to LG Household & Healthcare?
From the same area (Consumer Defensive) we also value The Procter & Gamble Company, Colgate-Palmolive Company, Hindustan Unilever Limited, Kenvue Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is LG Household & Healthcare stock attractive at the current price?
The data as of Sep 24, 2026: price 292,500 KRW, calculated fair value 197,812 KRW (−32%), Quality Score 57/100, from 14 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 051900 calculated?
We run LG Household & Healthcare through 14 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 197,812 KRW, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. LG Household & Healthcare itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of LG Household & Healthcare (051900)?
The closing price on Sep 23, 2026 was 292,500 KRW. Our model-based fair value is 197,812 KRW, about −32% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with LG Household & Healthcare right now?
The price sits above even our optimistic bull case (247,322 KRW). The favourable scenario is already priced in. Solid but not exceptional quality (57/100) and above fair value, neither a clear bargain nor a standout compounder.
Key figures of LG Household & Healthcare
How large is the market capitalisation of LG Household & Healthcare (051900)?
The market capitalisation of LG Household & Healthcare is 4.3T KRW (≈ $3.0B). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of LG Household & Healthcare (051900)?
The price-to-sales ratio of LG Household & Healthcare is 0.65 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the dividend yield of LG Household & Healthcare (051900)?
The dividend yield of LG Household & Healthcare is 0.7%. Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of LG Household & Healthcare (051900)?
The net margin of LG Household & Healthcare is −1.6% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of LG Household & Healthcare (051900)?
The return on equity (ROE) of LG Household & Healthcare is −1.8% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of LG Household & Healthcare (051900)?
On an EBIT basis the return on assets of LG Household & Healthcare is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of LG Household & Healthcare (051900)?
The operating margin of LG Household & Healthcare is 6.8% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at LG Household & Healthcare (051900)?
Revenue at LG Household & Healthcare is growing −7.1% versus a year earlier (3y avg −4.0%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at LG Household & Healthcare (051900)?
Earnings per share at LG Household & Healthcare are growing −14.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net debt does LG Household & Healthcare (051900) carry?
The net debt of LG Household & Healthcare is 3.3B KRW (fiscal year 2020, ≈ 0.0 yrs of FCF). Debt minus cash on hand. The note shows how many years of free cash flow could in theory pay it off.
Free · no account needed
Watch LG Household & Healthcare in the live analysis
One click puts LG Household & Healthcare on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
